| abstract |
The application describes indolinone derivatives substituted in position 6 of general formula (I) in which R-R and X have the meanings indicated in claim 1, their tautomers, enantiomers, diastereomers, their mixtures and their salts, primarily their physiologically compatible salts which possess valuable pharmacological properties, primarily inhibiting effect on various receptor tyrosine kinases, as well as on the proliferation of endothelial cells and various tumor cells, as well as drugs containing these compounds are described. The understanding of these compounds and the method of their preparation. The international application was published together with an international search report. |